Quanta Therapeutics
Clinical trials sponsored by Quanta Therapeutics, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug targets tough cancers with KRAS G12V mutation Results expected Jan 2027 (estimated)
- New drug targets tough cancer mutation in early trial Results expected Apr 2027 (estimated)